Cambridge Trust Co. Purchases 400 Shares of Colgate-Palmolive (NYSE:CL)

Cambridge Trust Co. grew its position in shares of Colgate-Palmolive (NYSE:CL) by 6.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,449 shares of the company’s stock after buying an additional 400 shares during the quarter. Cambridge Trust Co.’s holdings in Colgate-Palmolive were worth $514,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. &PARTNERS increased its position in Colgate-Palmolive by 0.7% during the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after acquiring an additional 129 shares during the last quarter. West Branch Capital LLC raised its position in Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the period. Gladstone Institutional Advisory LLC lifted its stake in Colgate-Palmolive by 2.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock worth $476,000 after purchasing an additional 133 shares during the last quarter. First Foundation Advisors boosted its position in shares of Colgate-Palmolive by 2.7% during the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after buying an additional 136 shares during the period. Finally, Waldron Private Wealth LLC grew its stake in shares of Colgate-Palmolive by 2.7% during the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after buying an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CL. Citigroup raised their price target on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price objective on the stock. Finally, Stifel Nicolaus raised their target price on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Stock Performance

NYSE CL opened at $86.30 on Friday. The firm has a market cap of $70.94 billion, a P/E ratio of 31.19, a P/E/G ratio of 3.26 and a beta of 0.42. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $90.37. The business’s 50-day moving average price is $87.02 and its 200 day moving average price is $80.67. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same quarter in the prior year, the firm earned $0.77 EPS. Colgate-Palmolive’s quarterly revenue was up 6.9% on a year-over-year basis. On average, equities research analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a $0.50 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.32%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 over the last quarter. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.